VINC
Vincerx Pharma
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
Signals Analysis
Buy signal 1
Sell signal 0
EPS Beats Expectation
Key Stats
--DAY`S RANGE--
--52 WK RANGE--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
About VINC
Vincerx Pharma, Inc.
A biopharmaceutical company that develops therapies for cancer
260 Sheridan Avenue, Suite 400, Palo Alto, CA 94306
--
Vincenx Pharma, Inc., was incorporated in Delaware on December 19, 2018. The purpose of the company merging with one or more businesses is to achieve a merger, share swap, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.
Company Financials
EPS
VINC has released its 2024 Q3 earnings. EPS was reported at -0.17, versus the expected -0.22, beating expectations. The chart below visualizes how VINC has performed over recent quarters, highlighting trends in earnings surprises.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
